Literature DB >> 4616933

Studies on bredinin. I. Isolation, characterization and biological properties.

K Mizuno, M Tsujino, M Takada, M Hayashi, K Atsumi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4616933     DOI: 10.7164/antibiotics.27.775

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  33 in total

1.  Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.

Authors:  A Zeevi; M Woan; G Z Yao; R Venkataramanan; S Todo; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.

Authors:  M Tanabe; S Todo; N Murase; W Irish; H Miyazawa; S Fujisaki; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.

Authors:  A Zeevi; G Z Yao; R Venkataramanan; R J Duquesnoy; S Todo; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.

Authors:  Shiro Takahara; Kota Takahashi; Takahiro Akiyama; Kazuharu Uchida; Kazunari Tanabe; Noritoshi Amada; Hiroshi Toma
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

Review 5.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

6.  The true distribution volume and bioavailability of mizoribine in children with chronic kidney disease.

Authors:  Takuhito Nagai; Osamu Uemura; Hisashi Kaneda; Katsumi Ushijima; Kazuhide Ohta; Yoshimitsu Gotoh; Kenichi Satomura; Masaki Shimizu; Mikiya Fujieda; Masashi Morooka; Takuji Yamada; Masayoshi Yamada; Naohiro Wada; Yukiya Hashimoto
Journal:  Clin Exp Nephrol       Date:  2016-11-21       Impact factor: 2.801

7.  Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.

Authors:  Y Igarashi; Y Moro; Y Kondo; C N Inoue
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

8.  Production of brefeldin-A.

Authors:  T G McCloud; M P Burns; F D Majadly; G M Muschik; D A Miller; K K Poole; J M Roach; J T Ross; W B Lebherz
Journal:  J Ind Microbiol       Date:  1995-07

9.  Successful treatment of refractory polymyositis with the immunosuppressant mizoribine: case report.

Authors:  A Suwa; M Hirakata; Y Kaneko; S Sato; Y Suzuki; M Kuwana
Journal:  Clin Rheumatol       Date:  2008-12-09       Impact factor: 2.980

Review 10.  Mizoribine: a new approach in the treatment of renal disease.

Authors:  Yukihiko Kawasaki
Journal:  Clin Dev Immunol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.